Hap Trading, LLC Checkpoint Therapeutics, Inc. Call Options Transaction History

Hap Trading, LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2022 Nov 14, 2022	SELL	$1.02 - $10.6 $18,360 - $190,800	-18,000 Reduced 58.44%	12,800 $0
Q2 2022 Aug 12, 2022	SELL	$0.97 - $1.77 $44,717 - $81,597	-46,100 Reduced 59.95%	30,800 $1,000
Q1 2022 May 12, 2022	BUY	$1.53 - $3.25 $74,052 - $157,300	48,400 Added 169.82%	76,900 $9,000
Q4 2021 Feb 14, 2022	BUY	$2.68 - $4.46 $76,380 - $127,110	28,500 New	28,500 $18,000

1.91M

Ticker CKPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 85,497,000
Market Cap $297M
Description
Checkpoint Therapeutics, Inc., clinical-stage immunotherapy and targeted oncology company, focuses on the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers. The company's lead antibody product candidate is Cosibelimab, a fully-human monoclonal antibody of IgG1 subtype that directly binds to...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.